Takeda allies with Frazier to spin out late-phase norovirus vaccine

Takeda allies with Frazier to spin out late-phase norovirus vaccine

Source: 
Fierce Biotech
snippet: 

Takeda has spun out its norovirus vaccine prospect to create a biotech: HilleVax. Frazier Healthcare Partners has teamed up with Takeda to found HilleVax, providing investor support for a program that cleared phase 2b back in 2018.